BILINSKY IGOR 4

4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Jun 3, 2026

AI-generated summary of this filing

Updated Jun 3, 2026

IOVANCE (IOVA) COO Igor Bilinsky Receives RSUs; Tax Withholding

What Happened

Igor Bilinsky, Chief Operating Officer of Iovance Biotherapeutics (IOVA), had 8,790 restricted stock units (RSUs) vest/convert to common stock on June 1, 2026. Of those, 4,473 shares were withheld by the issuer to satisfy mandatory tax withholding at $3.96 per share (total value $17,713). The vesting resulted in a net delivery of 4,317 shares to Bilinsky (8,790 vested minus 4,473 withheld).
This was not an open-market sale; the 4,473-share disposition reflects share withholding to cover taxes (cashless/withholding) rather than a sale for cash.

Key Details

Transaction date: 2026-06-01; Form 4 filed: 2026-06-03.
Vesting/conversion: 8,790 RSUs converted to common stock (reported as derivative exercise/conversion).
Tax withholding: 4,473 shares withheld at $3.96 each = $17,713 (footnote indicates withholding by issuer, not open-market sale).
Net shares received by insider: 4,317 common shares.
Additional notes from filing: each RSU equals one share; remaining RSUs from the March 1, 2024 grant will vest in equal quarterly installments.
Filing appears timely (reported two days after the transaction).

Context

RSU vesting and share-withholding for taxes is routine compensation administration and doesn’t necessarily signal buying or selling intent. Here the conversion of RSUs to stock and the withholding to satisfy taxes is effectively a cashless transaction rather than a market sale.
The filing includes a derivative line removing the RSU entitlement (standard when RSUs convert to common stock).

Form 4

Period: 2026-06-01

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-01+8,790→ 134,556 total
Tax Payment
Common Stock
[F2][F3]
2026-06-01$3.96/sh−4,473$17,713→ 130,083 total
Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]
2026-06-01−8,790→ 26,369 total
→ Common stock (8,790 underlying)

Footnotes (6)

[F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
[F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
[F3]Represents common stock remaining after deducting the common stock withheld for taxes.
[F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
[F5]The remaining RSUs will vest in equal quarterly installments.
[F6]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Signature

/s/ Igor Bilinsky|2026-06-03

1 file